Elicio Therapeutics (ELTX) Long-Term Debt Issuances (2020 - 2025)

Name: Elicio Therapeutics (ELTX) Long-Term Debt Issuances (2020 - 2025) | Business Quant
Creator: Business Quant

Elicio Therapeutics posted quarterly Long-Term Debt Issuances of -$9.9 million for Q3 2025, down 1464.59% on a QoQ basis from $723000.0 in Q2 2025.

Elicio Therapeutics (ELTX) has 3 years of Long-Term Debt Issuances data on file, last reported at -$9.9 million in Q3 2025.

For the quarter ending Q3 2025, Long-Term Debt Issuances changed N/A year-over-year to -$9.9 million; the trailing twelve-month figure through Mar 2026 stood at -$9.1 million (down 200.0% YoY), and the FY2020 full-year result was $31.2 million, changed N/A from the prior year.
Long-Term Debt Issuances for Q3 2025 stood at -$9.9 million, down from $723000.0 in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at $10.0 million in Q1 2023 and bottomed at -$10.0 million in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	2.73 Mn
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	-
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	-
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Elicio Therapeutics	217.63 Mn	202.68 Mn	-	-

Download Data 🔒